Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan

Area of Science:

• Neurology
• Pharmacology

Background:

• Migraine is a common neurological disorder.
• Sumatriptan is a widely used medication for acute migraine attacks.

Observation:

• A case report details a 39-year-old man experiencing a fatal cerebellar infarction.
• The infarction occurred during sumatriptan therapy for an acute migraine episode.

Findings:

• Cerebellar infarction, a type of stroke affecting the cerebellum, was the cause of death.
• Intracranial vasospasm, the narrowing of blood vessels in the brain, is proposed as the mechanism linking sumatriptan to the infarction.

Implications:

• This case highlights a potential rare but serious adverse effect of sumatriptan.
• Further research into the relationship between triptans and cerebrovascular events is warranted.
• Consideration of vasospasm as a potential complication during sumatriptan therapy is important for clinical practice.